Key result
Testing of 10 ion channel blockers on human-induced pluripotent stem cell cardiomyocytes demonstrated relevant pharmacology and excellent correlation with current functional cardiac electrophysiological studies.
Why the study?
Do human-induced pluripotent stem cell cardiomyocytes provide a reliable surrogate for preclinical in vitro electrophysiological safety screening?
Do human-induced pluripotent stem cell cardiomyocytes provide a reliable surrogate for preclinical in vitro electrophysiological safety screening?
Human-induced pluripotent stem cell cardiomyocytes on multielectrode arrays demonstrate relevant pharmacology and correlate well with existing functional cardiac electrophysiological studies, offering a reliable surrogate for preclinical safety screening.
Answers are grounded in this paper and cite their sources.
hiPSC-CMs may support in vitro safety screening; leaves open clinical cardiotoxicity translation.
Human-induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) are a potential source to develop assays for predictive electrophysiological safety screening. Published studies show that the relevant physiology and pharmacology exist but does not show the translation between stem cell cardiomyocyte assays and other preclinical safety screening assays, which is crucial for drug discovery and safety scientists and the regulators. Our studies are the first to show the pharmacology of ion channel blockade and compare them with existing functional cardiac electrophysiology studies. Ten compounds (a mixture of pure hERG [E-4031 and Cisapride], hERG and sodium [Flecainide, Mexiletine, Quinidine, and Terfenadine], calcium channel blockers [Nifedipine and Verapamil], and two proprietary compounds [GSK A and B]) were tested, and results from hiPSC-CMs studied on multielectrode arrays (MEA) were compared with other preclincial models and clinical drug concentrations and effects using integrated risk assessment plots. All ion channel blockers produced (1) functional effects on repolarization and depolarization around the IC25 and IC50 values and (2) excessive blockade of hERG and/or blockade of sodium current precipitated arrhythmias. Our MEA data show that hiPSC-CMs demonstrate relevant pharmacology and show excellent correlations to current functional cardiac electrophysiological studies. Based on these results, MEA assays using iPSC-CMs offer a reliable, cost effective, and surrogate to preclinical in vitro testing, in addition to the 3Rs (refine, reduce, and replace animals in research) benefit.
No takes yet. Share an insight, caveat, or question.
Harris et al. (2013) studied Electrophysiological safety screening. 10 ion channel blocking compounds vs. Other preclinical models and clinical drug concentrations was evaluated on Functional effects on repolarization and depolarization and precipitation of arrhythmias. Testing of 10 ion channel blockers on human-induced pluripotent stem cell cardiomyocytes demonstrated relevant pharmacology and excellent correlation with current functional cardiac electrophysiological studies.
Synapse has enriched 10 related papers. Consider them for comparative context: